Foghorn Therapeutics
Develops oncology drugs from a Gene Traffic Control discovery platform.
$6.00
After-hours close0.00 (0.00%)
At close$6.00(−3.54%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 75.69%44.44M sharesInsiders 0.41%240.8K sharesOther 23.90%14.03M shares
Shares outstanding 58.71M · Float 27.41M · 46.7% free float
Institutions13F, as of Mar 31, 2026
104 holders · 44.44M shares · 22 new positions · 62 increased · 20 reduced · 11 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Flagship Pioneering Inc. | 12.67M | 21.59% | 0 | May 15, 2026 |
| FMR LLC | 6.05M | 10.30% | +650.4K | May 15, 2026 |
| BVF Inc/IL | 5.84M | 9.95% | +540.0K | May 15, 2026 |
| Deerfield Management Company, L.P. (Series C) | 4.39M | 7.48% | +745.2K | May 15, 2026 |
| Raymond James Financial Inc | 2.60M | 4.43% | +96.6K | May 14, 2026 |
| BlackRock, Inc. | 2.36M | 4.03% | +15.0K | May 13, 2026 |
| Euclidean Capital LLC | 1.57M | 2.68% | 0 | May 15, 2026 |
| Vanguard Capital Management LLC | 1.50M | 2.55% | +1.50Mnew | May 15, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Noubar Afeyanincl. Flagship Pioneering Fund VII General Partner LLC, Flagship Pioneering Fund VII, L.P. +7 more | 27.20% | 20.77M | 13D | Jan 13, 2026 ↗ |
| FMR LLC | 11.60% | 6.79M | 13G | May 6, 2026 ↗ |
| Deerfield Mgmt, L.P. | 8.64% | 5.14M | 13G | May 14, 2026 ↗ |
| Biotechnology Value Fund L P | 5.40% | 3.16M | 13G | May 15, 2026 ↗ |
| Deerfield Partners, L.P.incl. Deerfield Management Company, L.P., James E. Flynn +1 more | 5.31% | 2.94M | 13G | Sep 20, 2024 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Adrian Gottschalk | director, officer: Chief Executive Officer | 240.8K | 0.41% | Apr 13, 2026 |
2 ten-percent owners hold 2.52M shares by Form 4, outside the officers-and-directors figure above · 8 people have not refiled in the last 18 months (1.09M shares), so they are not in the figure above
Latest trades
No open-market trades in the last 12 months.
CongressHouse and Senate disclosures
Not reported.